Serial assessment of tissue growth inside and outside the stent after implantation of drug-eluting stent in clinical trials. - Does delayed neointimal growth exist? - Suppr | 超能文献

Serial assessment of tissue growth inside and outside the stent after implantation of drug-eluting stent in clinical trials. - Does delayed neointimal growth exist?

作者信息

Aoki Jiro, Abizaid Alexandre C, Ong Andrew T L, Tsuchida Keiichi, Serruys Patrick W

机构信息

Thoraxcenter Erasmus MC, Rotterdam, the Netherlands.

出版信息

EuroIntervention. 2005 Nov;1(3):235-55.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Serial assessment of tissue growth inside and outside the stent after implantation of drug-eluting stent in clinical trials. - Does delayed neointimal growth exist?

EuroIntervention. 2005 Nov;1(3):235-55.

2

Angioscopic findings after drug-eluting stent implantation.

Herz. 2007 Jun;32(4):281-6. doi: 10.1007/s00059-007-2996-x.

3

A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.

EuroIntervention. 2011 May;7 Suppl K:K93-9. doi: 10.4244/EIJV7SKA16.

4

Relationship between neointimal coverage of sirolimus-eluting stents and lesion characteristics: a study with serial coronary angioscopy.

Am Heart J. 2009 Jul;158(1):99-104. doi: 10.1016/j.ahj.2009.04.016.

5

ComparisOn of neointimal coVerage betwEen zotaRolimus-eluting stent and everolimus-eluting stent using Optical Coherence Tomography (COVER OCT).

Am Heart J. 2012 Apr;163(4):601-7. doi: 10.1016/j.ahj.2011.10.016.

6

Drug-eluting stents.

Arch Cardiol Mex. 2006 Jul-Sep;76(3):297-319.

7

Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study.

Am Heart J. 2003 Aug;146(2):E5. doi: 10.1016/S0002-8703(03)00146-7.

8

Impact of polymer formulations on neointimal proliferation after zotarolimus-eluting stent with different polymers: insights from the RESOLUTE trial.

Circ Cardiovasc Interv. 2011 Jun;4(3):248-55. doi: 10.1161/CIRCINTERVENTIONS.110.957548. Epub 2011 May 17.

9

Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.

Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550.

10

Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation.

Am J Cardiol. 2007 Apr 15;99(8):1033-8. doi: 10.1016/j.amjcard.2006.11.068. Epub 2007 Feb 23.

引用本文的文献

1

Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study.

Eur Heart J. 2010 May;31(9):1055-64. doi: 10.1093/eurheartj/ehp476. Epub 2009 Nov 18.

2

Update on stents: recent studies on the TAXUS stent system in small vessels.

Vasc Health Risk Manag. 2007;3(4):481-90.